Literature DB >> 10620541

Racial variation in autosomal dominant polycystic kidney disease.

B I Freedman1, J M Soucie, A Chapman, J Krisher, W M McClellan.   

Abstract

These analyses were undertaken to determine whether racial variation contributes to the risk of end-stage renal disease (ESRD) in close relatives of incident dialysis patients with autosomal dominant polycystic kidney disease (ADPKD)-associated ESRD. A family history of ESRD was recorded in 14,769 incident ESRD patients in Network 6 (Georgia, North Carolina, South Carolina) between September 1993 and November 1997. Two hundred thirty-seven patients with ADPKD-ESRD comprised the study population (180 white and 57 black). Differences in patient populations were analyzed using the chi-squared and Student's t-tests, and multiple regression analysis was performed. Correlation in age at ESRD onset in families was performed by linear regression analysis. A positive family history (FH) of ESRD in first- or second-degree relatives was reported by 38.6% (22 of 57) of blacks and 55% (99 of 180) of whites (P = 0.03). The 22 blacks with a positive FH had a mean of 2.0 additional ESRD relatives and 10.4 total first-degree relatives, whereas the 99 whites with a positive FH had a mean of 2.6 additional ESRD relatives and 7.0 total first-degree relatives (P = 0.14 and P < 0.001, respectively). Mean age in years at first dialysis was similar in blacks and whites, regardless of FH (black FH positive, 63.8; black FH negative, 66.3; P = 0.66; white FH positive, 60.8; white FH negative, 62.8; P = 0. 48). On average, 57.9% of the first- and second-degree relatives of white cases had ADPKD-associated ESRD, compared with 28.6% of the relatives of black cases (P < 0.001). In the multivariate analysis, white race (P = 0.004) and increasing family size (P = 0.002) were positively correlated with the number of relatives having ADPKD-associated ESRD, whereas age at ESRD onset (P = 0.50) and gender (P = 0.94) were not. Age at onset of ESRD was correlated within members of multiply affected white (P < 0.001) but not black families (P = 0.80). We conclude that blacks with ADPKD-associated ESRD are less likely than whites to have relatives with ESRD, and there is no correlation in age at onset of ADPKD-ESRD in black families.

Entities:  

Mesh:

Year:  2000        PMID: 10620541     DOI: 10.1016/S0272-6386(00)70298-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Renal function and healthcare costs in patients with polycystic kidney disease.

Authors:  Krista L Lentine; Huiling Xiao; Gerardo Machnicki; Adrian Gheorghian; Mark A Schnitzler
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Autosomal Dominant Polycystic Kidney Disease Prevalence among a Racially Diverse United States Population, 2002 through 2018.

Authors:  Thet T Aung; Simran K Bhandari; Qiaoling Chen; Fatima T Malik; Cynthia J Willey; Kristi Reynolds; Steven J Jacobsen; John J Sim
Journal:  Kidney360       Date:  2021-09-22

3.  Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.

Authors:  Rita L McGill; Milda R Saunders; Alexandra L Hayward; Arlene B Chapman
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-20       Impact factor: 10.614

4.  Polycystin-1 regulates the stability and ubiquitination of transcription factor Jade-1.

Authors:  Rebecca L Foy; Vipul C Chitalia; Maria V Panchenko; Liling Zeng; Delia Lopez; Jean W Lee; Shaunak V Rana; Alessandra Boletta; Feng Qian; Leonidas Tsiokas; Klaus B Piontek; Gregory G Germino; Mina I Zhou; Herbert T Cohen
Journal:  Hum Mol Genet       Date:  2012-09-21       Impact factor: 6.150

5.  ADPKD: Prototype of Cardiorenal Syndrome Type 4.

Authors:  Grazia Maria Virzì; Valentina Corradi; Anthi Panagiotou; Fiorella Gastaldon; Dinna N Cruz; Massimo de Cal; Maurizio Clementi; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-12-21

6.  Revisiting racial differences in ESRD due to ADPKD in the United States.

Authors:  Erin L Murphy; Feng Dai; Katrina Lehmann Blount; Madeline L Droher; Lauren Liberti; Deidra C Crews; Neera K Dahl
Journal:  BMC Nephrol       Date:  2019-02-14       Impact factor: 2.388

7.  RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.

Authors:  Hyunjin Ryu; Hayne C Park; Yun Kyu Oh; Irene Sangadi; Annette Wong; Changlin Mei; Tevfik Ecder; Angela Yee-Moon Wang; Tze-Wah Kao; Jenq-Wen Huang; Gopala K Rangan; Curie Ahn
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

8.  Polycystic kidney disease.

Authors:  Pamela J Fall; L Michael Prisant
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-10       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.